Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherBasic Science (Animal or Phantoms)
Open Access

212Pb Alpha-Radioimmunotherapy targeting CD38 in Multiple Myeloma: a preclinical study.

Isabelle QUELVEN, Jacques Monteil, Magali Sage, Amal Saidi, Jeremy Mounier, Audrey Bayout, Julie Garrier, Michel Cogne and Stephanie Durand-Panteix
Journal of Nuclear Medicine December 2019, jnumed.119.239491; DOI: https://doi.org/10.2967/jnumed.119.239491
Isabelle QUELVEN
1 Nuclear Medicine Department, Limoges University Hospital, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jacques Monteil
1 Nuclear Medicine Department, Limoges University Hospital, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Magali Sage
2 CNRS UMR 7276 - INSERM U1262, CRIBL, Limoges University, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amal Saidi
3 Orano Med SAS, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy Mounier
2 CNRS UMR 7276 - INSERM U1262, CRIBL, Limoges University, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Audrey Bayout
1 Nuclear Medicine Department, Limoges University Hospital, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Julie Garrier
2 CNRS UMR 7276 - INSERM U1262, CRIBL, Limoges University, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel Cogne
2 CNRS UMR 7276 - INSERM U1262, CRIBL, Limoges University, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephanie Durand-Panteix
2 CNRS UMR 7276 - INSERM U1262, CRIBL, Limoges University, France;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

jnumed.119.239491
DOI 
https://doi.org/10.2967/jnumed.119.239491
PubMed 
31862796

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online December 20, 2019.

Article Versions

  • You are currently viewing a previous version of this article (December 20, 2019 - 13:25).
  • View the most recent version of this article
Copyright & Usage 
Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Isabelle QUELVEN1,
  2. Jacques Monteil1,
  3. Magali Sage2,
  4. Amal Saidi3,
  5. Jeremy Mounier2,
  6. Audrey Bayout1,
  7. Julie Garrier2,
  8. Michel Cogne2 and
  9. Stephanie Durand-Panteix2
  1. 1 Nuclear Medicine Department, Limoges University Hospital, France;
  2. 2 CNRS UMR 7276 - INSERM U1262, CRIBL, Limoges University, France;
  3. 3 Orano Med SAS, France
  1. For correspondence or reprints contact: Michel Cogne, CNRS UMR 7276 - INSERM U1262, CRIBL, Limoges University, 2 rue Dr Marcland, Limoges 87025, France. E-mail: michel.cogne@unilim.fr

Statistics from Altmetric.com

Cited By...

  • 28 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • 212Pb: Production Approaches and Targeted Therapy Applications
    Konstantin V. Kokov, Bayirta V. Egorova, Marina N. German, Ilya D. Klabukov, Michael E. Krasheninnikov, Antonius A. Larkin-Kondrov, Kseniya A. Makoveeva, Michael V. Ovchinnikov, Maria V. Sidorova, Dmitry Y. Chuvilin
    Pharmaceutics 2022 14 1
  • Targeted Therapy With Immunoconjugates for Multiple Myeloma
    Wassilis S. C. Bruins, Sonja Zweegman, Tuna Mutis, Niels W. C. J. van de Donk
    Frontiers in Immunology 2020 11
  • 203/212Pb Theranostic Radiopharmaceuticals for Image-guided Radionuclide Therapy for Cancer
    Mengshi Li, Edwin A. Sagastume, Dongyoul Lee, Daniel McAlister, Anthony J. DeGraffenreid, Keith R. Olewine, Stephen Graves, Roy Copping, Saed Mirzadeh, Brian E. Zimmerman, Roy H. Larsen, Frances L. Johnson, Michael K. Schultz
    Current Medicinal Chemistry 2020 27 41
  • Comparison of CD38-Targeted α- Versus β-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
    Megan Minnix, Vikram Adhikarla, Enrico Caserta, Erasmus Poku, Russell Rockne, John E. Shively, Flavia Pichiorri
    Journal of Nuclear Medicine 2021 62 6
  • Tailoring radiotherapies and nanotechnology for targeted treatment of solid tumors
    Muhammad Imran Khan, Fakhra Batool, Rizwan Ali, Qurat ul Ain Zahra, Wenshen Wang, Shibo Li, Gangguo Wang, Liangliang Liu, Safir Ullah Khan, Majad Mansoor, Muhammad Bilal, Weiping Ding, Ahsan Kazmi, Fenfen Li, Bensheng Qiu
    Coordination Chemistry Reviews 2022 472
  • A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma
    Elodie Duray, Margaux Lejeune, Frederic Baron, Yves Beguin, Nick Devoogdt, Ahmet Krasniqi, Yoline Lauwers, Yong Juan Zhao, Matthias D’Huyvetter, Mireille Dumoulin, Jo Caers
    Journal of Hematology & Oncology 2021 14 1
  • CS1-specific single-domain antibodies labeled with Actinium-225 prolong survival and increase CD8+ T cells and PD-L1 expression in Multiple Myeloma
    Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens, Serge Muyldermans, Karine Breckpot, Frank Bruchertseifer, Alfred Morgenstern, Matthias D’Huyvetter, Nick Devoogdt
    OncoImmunology 2021 10 1
  • Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma
    Stéphanie Durand-Panteix, Jacques Monteil, Magali Sage, Armand Garot, Marie Clavel, Amal Saidi, Julien Torgue, Michel Cogne, Isabelle Quelven
    British Journal of Cancer 2021 125 12
  • Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease
    Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, Delphine Dansette, Clément Bailly, François Guérard, Nicolas Chouin, Ferid Haddad, Cyril Alliot, Joëlle Gaschet, Romain Eychenne, Françoise Kraeber-Bodéré, Michel Chérel
    Cancers 2020 12 9
  • High-yield cyclotron production of 203Pb using a sealed 205Tl solid target
    Bryce J.B. Nelson, John Wilson, Michael K. Schultz, Jan D. Andersson, Frank Wuest
    Nuclear Medicine and Biology 2023 116-117

Article usage

Article usage: December 2019 to April 2025

AbstractFullPdf
Dec 20192840115
Jan 20203410312
Feb 2020311073
Mar 2020247068
Apr 2020168050
May 202050038
Jun 202056046
Jul 2020110469282
Aug 20203392567
Sep 20202931536
Oct 20201773443
Nov 2020881731
Dec 2020611935
Jan 2021434661
Feb 2021403768
Mar 2021153136
Apr 2021345223
May 2021245238
Jun 2021134723
Jul 2021194437
Aug 2021204946
Sep 2021173126
Oct 2021273766
Nov 2021173444
Dec 2021235344
Jan 2022273950
Feb 2022194428
Mar 2022203539
Apr 2022205034
May 2022235436
Jun 2022192930
Jul 2022123029
Aug 2022102626
Sep 2022123828
Oct 2022214238
Nov 2022164323
Dec 2022154124
Jan 2023317935
Feb 2023143323
Mar 2023213922
Apr 2023263326
May 2023313028
Jun 2023393316
Jul 2023362925
Aug 2023332725
Sep 202352225
Oct 2023192727
Nov 2023213616
Dec 2023193729
Jan 2024194821
Feb 2024183223
Mar 2024183958
Apr 20245322573
May 2024324530
Jun 2024373428
Jul 2024392827
Aug 20242348263
Sep 2024153832
Oct 2024194944
Nov 2024155626
Dec 2024233135
Jan 2025224121
Feb 2025417827
Mar 2025288751
Apr 2025304844
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (6)
Journal of Nuclear Medicine
Vol. 66, Issue 6
June 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
212Pb Alpha-Radioimmunotherapy targeting CD38 in Multiple Myeloma: a preclinical study.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
212Pb Alpha-Radioimmunotherapy targeting CD38 in Multiple Myeloma: a preclinical study.
Isabelle QUELVEN, Jacques Monteil, Magali Sage, Amal Saidi, Jeremy Mounier, Audrey Bayout, Julie Garrier, Michel Cogne, Stephanie Durand-Panteix
Journal of Nuclear Medicine Dec 2019, jnumed.119.239491; DOI: 10.2967/jnumed.119.239491

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
212Pb Alpha-Radioimmunotherapy targeting CD38 in Multiple Myeloma: a preclinical study.
Isabelle QUELVEN, Jacques Monteil, Magali Sage, Amal Saidi, Jeremy Mounier, Audrey Bayout, Julie Garrier, Michel Cogne, Stephanie Durand-Panteix
Journal of Nuclear Medicine Dec 2019, jnumed.119.239491; DOI: 10.2967/jnumed.119.239491
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Preclinical Investigation of [212Pb]Pb-DOTAM-GRPR1 for Peptide Receptor Radionuclide Therapy in a Prostate Tumor Model
  • Comparison of CD38-Targeted {alpha}- Versus {beta}-Radionuclide Therapy of Disseminated Multiple Myeloma in an Animal Model
  • Google Scholar

Similar Articles

Keywords

  • hematology
  • Radioimmunoimaging
  • radionuclide therapy
  • 212Pb
  • Alpha-radioimmunotherapy
  • CD38
  • multiple myeloma
SNMMI

© 2025 SNMMI

Powered by HighWire